Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Lisa Tarasenko"'
Autor:
Eric J. Roeland, Florian J. Fintelmann, Fiona Hilton, Ruoyong Yang, Ed Whalen, Lisa Tarasenko, Roberto A. Calle, Philip D. Bonomi
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 3, Pp 1030-1040 (2024)
Abstract Background This post hoc, pooled analysis examined the relationship between different weight gain categories and overall survival (OS) in patients with non‐small cell lung cancer (NSCLC) receiving first‐line platinum‐based chemotherapy
Externí odkaz:
https://doaj.org/article/9ed4059b5d9046c2a7abd34900b45e90
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 2, Pp 706-729 (2023)
Abstract Anorexia/appetite loss in older subjects is frequently underrecognized in clinical practice, which may reflect deficient understanding of clinical sequelae. Therefore, we performed a systematic literature review to assess the morbidity and m
Externí odkaz:
https://doaj.org/article/3715c04f3d714f6c907f5f94040a9cd7
Autor:
Anil Tarachandani, Fikret Isik Karahanoglu, Andrew Messere, Lisa Tarasenko, Ann-Marie LaRonde-Richard, Nancy Kessler, Michelle Rossulek, Hans Plate, Kim Mahoney, Mar Santamaria
Publikováno v:
Patient Preference and Adherence.
Anil Tarachandani,1 Fikret Isik Karahanoglu,1 Andrew Messere,1 Lisa Tarasenko,2 Ann-Marie LaRonde-Richard,3 Nancy Kessler,4 Michelle Rossulek,3 Hans Plate,5 Kim Mahoney,5 Mar Santamaria1 1Early Clinical Development, Pfizer Inc., Cambridge, MA, USA; 2
Autor:
Lisa Tarasenko, Bernard Charbonnel, Misoo C. Ellison, Susan Huyck, Annpey Pong, Shrita Patel, Steven G. Terra, Anne Hickman, Ira Gantz, Jie Liu, Richard E. Pratley, Samuel Dagogo-Jack
Publikováno v:
Diabetes, Obesity and Metabolism. 22:2276-2286
Aim To assess the efficacy and safety of ertugliflozin in older patients with type 2 diabetes (T2D). Materials and methods This is a post hoc analysis of patients with T2D aged less than 65 years and those aged 65 years or older who participated in r
Autor:
Lisa Tarasenko, Annpey Pong, Roberto A. Calle, Annaswamy Raji, Silvina Gallo, Steven G. Terra
Publikováno v:
Diabetes Therapy
Introduction This post hoc exploratory analysis examined the effects of ertugliflozin on liver enzymes in patients with type 2 diabetes mellitus (T2DM). Methods Data were pooled from seven randomized, double-blind VERTIS phase 3 trials that evaluated
Autor:
Anne Hickman, Shrita Patel, Larry Wu, Lisa Tarasenko, Ira Gantz, Jie Liu, James P. Mancuso, Susan Huyck, Annpey Pong, Steven G. Terra
Publikováno v:
Current Medical Research and Opinion. 36:1277-1284
Objective: To assess the efficacy and safety of the sodium-glucose cotransporter 2 inhibitor ertugliflozin across racial groups in patients with type 2 diabetes mellitus (T2DM).Methods: Pooled analysis of data from randomized, double-blind studies in
Publikováno v:
Innovation in Aging. 6:271-271
The scope of the clinical problem of anorexia or appetite loss (AL) in older populations is potentially under-appreciated. A systematic literature review (SLR) was conducted following PRISMA guidelines to summarize associations of anorexia/AL in olde
Autor:
Steven G. Terra, Lisa Tarasenko, Jie Liu, James P. Mancuso, Silvina Gallo, Annpey Pong, Roberto A. Calle, Amanda Darekar, Susan Huyck, Larry Wu
Publikováno v:
Diabetes and Vascular Disease Research. 16:415-423
Background: This pooled analysis assessed the efficacy of ertugliflozin versus placebo as monotherapy or with other antihyperglycaemic agents across patient subgroups defined by demographic and disease characteristics. Methods: Data from three phase
Autor:
Eric Roeland, Florian J. Fintelmann, Fiona Hilton, Lisa Tarasenko, Roberto A Calle, Philip D. Bonomi
Publikováno v:
Journal of Clinical Oncology. 40:9088-9088
9088 Background: Cachexia is a multifactorial syndrome frequently associated with cancer characterized by anorexia and unintentional weight loss, including skeletal muscle loss, fatigue, functional impairment, poor quality of life, and worse survival
Autor:
Steven G. Terra, Misoo C. Ellison, Lisa Tarasenko, Jie Liu, Anne Hickman, Ira Gantz, James P. Mancuso, Annpey Pong, Shrita Patel, Susan Huyck
Objective: To assess the efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes (T2DM). Methods: Analysis of data from Hispanic/Latino patients who participated in randomized, double-blind phase III studies. Ertuglifloz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f1c53449eaf82988cbcde729c3a0252